Finding links between genetic markers and the end phenotype can be difficult – especially with complex diseases, such as Alzheimer’s and Schizophrenia, where a multitude of other environmental factors affect disease development. In an attempt to close the gap, researchers from the University of Pittsburgh and Pfizer have announced a collaboration that aims to create a statistical model that relates brain scan data to genetic profiles (1). We spoke with Kayhan Batmanghelich, principle investigator and Assistant Professor in the Department of Biomedical Informatics in the School of Medicine, to tell us more about the collaboration.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
References
- University of Pittsburgh, “Pitt, Pfizer Team Up on Health Data Analytics”, (2016). Available at: http://bit.ly/2juQnHX. Last accessed January 11, 2017.
